INGRID MARTINEZ-LYONS: Open Payments
NPI 1013019710 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 24 payments from 7 companies in 2025. Trend: 2023 $796 · 2024 $636 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $114 |
| Alkermes, Inc. | 5 | $103 |
| ABBVIE INC. | 4 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: AUSTEDO XR, ARISTADA, VRAYLAR, CAPLYTA, REXULTI, COBENFY, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
